Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT01391247
Collaborator
(none)
59
1
11
5.4

Study Details

Study Description

Brief Summary

Retinal ischemia is thought to play an important role in the pathogenesis of glaucoma. Up until today, very little is known about the metabolic alterations in the retina of glaucoma patients, since only techniques for surrogate measurements of metabolism (like blood flow velocities and vessel diameter) were available. Oximetry has provided us with an important tool to study metabolism in glaucoma, and to correlate these findings with the available blood flow evaluation techniques. Preliminary results by the group of Prof Stefánsson (2011) with the dual wavelength oximeter pointed out that deeper glaucomatous visual field defects are associated with decreased arteriovenous differences in retinal oxygen saturation. These data suggest that a change in oxygen metabolism occurs in glaucomatous retina. This reduced oxygen metabolism may be related to tissue atrophy. However, this explanation is still hypothetical, since the relation between these oximetry results and structural changes in the optic nerve have not been studied yet.

  1. What are the oximetry values in a normal population of within the same age group as the glaucoma population? To answer this question, a normative database of the investigators retinal oximetry device needs to be constructed for healthy controls.

  2. Do glaucoma patients have different retinal oximetry values than these normal patients? Are there any differences in retinal oxygenation between these glaucoma groups? To answer these questions, oximetry measurements will be performed in patients with normal tension glaucoma (NTG) and primary open angle glaucoma (POAG).

  3. Is there an association between structural optic disc and retinal nerve fibre layer changes, using Heidelberg Retinal Tomography (HRT), with alterations in retinal vascular oxygen saturation in NTG and POAG patients?

  4. Are blood flow measurements, using colour Doppler imaging (CDI), correlated with alteration in retinal vascular oxygen in NTG and POAG patients?

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    1. Oximetry pictures will be taken and analysed.

    2. CDI exam will be performed.

    3. Visual field examen will be performed.

    4. HRT will be performed.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    59 participants
    Time Perspective:
    Prospective
    Official Title:
    Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation
    Study Start Date :
    Jan 1, 2011
    Actual Primary Completion Date :
    Dec 1, 2011
    Actual Study Completion Date :
    Dec 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    healthy age machted controls

    normal tension glaucoma patients

    primary open angle glaucoma patients

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of oxygen saturation between glaucoma patients and healthy controls. [patients will be followed during their hospital stay, an average. of 3 hours]

      Retinal oximetry gives us oxygen saturation values who will be compared between glaucoma patients and healthy controls and will be correlated to visual field mean defect, structure parameters from the HRT and velocity measurements with the CDI.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • individuals over 18 years old

    • willing to sign an informed consent and able to comply with the requirements of the study

    • having no other ocular diseases besides glaucoma

    Exclusion Criteria:
    • history of ocular trauma

    • intraocular surgery (except for cataract surgery)

    • eye disease (except glaucoma)

    • systemic diseases with ocular involvement like diabetes

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Ophthalmology, UZLeuven Leuven Belgium 3000

    Sponsors and Collaborators

    • Universitaire Ziekenhuizen Leuven

    Investigators

    • Principal Investigator: Ingeborg Stalmans, MD, Phd, Universitaire Ziekenhuizen Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Universitaire Ziekenhuizen Leuven
    ClinicalTrials.gov Identifier:
    NCT01391247
    Other Study ID Numbers:
    • S52610
    First Posted:
    Jul 11, 2011
    Last Update Posted:
    Feb 6, 2013
    Last Verified:
    Dec 1, 2010
    Keywords provided by Universitaire Ziekenhuizen Leuven
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 6, 2013